aspirin inc

9
Copyright © 2009 Driven Forward Aspirin Inc. Aspirin Inc. The Cure For The Common Headache The Cure For The Common Headache Investor Presentation Investor Presentation

Upload: glen-hellman

Post on 01-Dec-2014

1.153 views

Category:

Documents


2 download

DESCRIPTION

Sample Investor Presentation.

TRANSCRIPT

Page 1: Aspirin Inc

Copyright © 2009 Driven Forward

Aspirin Inc.Aspirin Inc.The Cure For The Common HeadacheThe Cure For The Common Headache

Investor PresentationInvestor Presentation

Page 2: Aspirin Inc

Copyright © 2009 Driven Forward

What if your head hurt so badWhat if your head hurt so bad

• you couldn’t seeyou couldn’t see

• you couldn’t driveyou couldn’t drive

• you couldn’t workyou couldn’t work

• You couldn't care for You couldn't care for your childrenyour children

• you couldn’t function you couldn’t function

45 million Americans suffer 45 million Americans suffer chronicchronic headaches headaches

Page 3: Aspirin Inc

Copyright © 2009 Driven Forward

What if a pill could make the pain What if a pill could make the pain go way in minutes?go way in minutes?

• Relief is just Relief is just seconds awayseconds away

• 90% efficacy90% efficacy

• Proprietary Proprietary Patented Patented TechnologyTechnology

What would 45 million people pay for instant relief?What would 45 million people pay for instant relief?

Page 4: Aspirin Inc

Copyright © 2009 Driven Forward

Conservative Revenue Projections

$0

$20

$40

$60

$80

$100

$120

$140

$160

2009 2010 2011 2012 2013

Enormous MarketEnormous Market

45M Americans x 2 headaches per month45M Americans x 2 headaches per month1B Headaches per year1B Headaches per year$2B Per Year Market @ $2.00 per pill $2B Per Year Market @ $2.00 per pill

Page 5: Aspirin Inc

Copyright © 2009 Driven Forward

Management TeamManagement Team

• CEO – Mary SmithCEO – Mary Smith– Founder/CEO BigProfitableCo acquired by EvenBiggerCo for Founder/CEO BigProfitableCo acquired by EvenBiggerCo for

a 12X ROI to Investorsa 12X ROI to Investors– University of Maryland RH Smith MBAUniversity of Maryland RH Smith MBA

• CFO – Bob AndweveCFO – Bob Andweve– CFO Big Pharma R&D DivisionCFO Big Pharma R&D Division– Harvard MBAHarvard MBA

• VP Sales & Marketing – Sally CansellVP Sales & Marketing – Sally Cansell– Grew Bandaid Inc Pharma Div Sales from $0 to $40M in 4 Grew Bandaid Inc Pharma Div Sales from $0 to $40M in 4

yearsyears– Once sold ice to an InuitOnce sold ice to an Inuit

• COO– Tom CandoCOO– Tom Cando– 12 years as Manufacturing Head of Placebo Pills Inc12 years as Manufacturing Head of Placebo Pills Inc

Been There, Done ThatBeen There, Done That

Page 6: Aspirin Inc

Copyright © 2009 Driven Forward

Go To MarketGo To Market

• Scalable contract manufacturing Scalable contract manufacturing agreement in placeagreement in place

• Sales Team with strong Sales Team with strong relationships with 5 of the top 8 relationships with 5 of the top 8 drug storesdrug stores

• In negotiations with Asian and In negotiations with Asian and European distributors European distributors

Ready For SuccessReady For Success

Page 7: Aspirin Inc

Copyright © 2009 Driven Forward

CompetitionCompetition

SpeedSpeed FastFastSlowSlow

AspirinAspirin

Effe

ctiv

enes

sE

ffect

iven

ess

Hig

hH

igh

Low

Low

Hammer

Coffee

Tea

Page 8: Aspirin Inc

Copyright © 2009 Driven Forward

FinancialsFinancials(US Dollars In Millions)(US Dollars In Millions)

-$10

$10

$30

$50

$70

$90

$110

$130

2009 2010 2011 2012 2013

SalesEBITA

EBITA – Earnings before Investments, Taxes and Amortization

Page 9: Aspirin Inc

Copyright © 2009 Driven Forward

Funding and FinanceFunding and Finance

• $5 Million Raise$5 Million Raise– ““A” RoundA” Round– No Additional Rounds AnticipatedNo Additional Rounds Anticipated

• Use of FundsUse of Funds– $1 Million for Intellectual Property Protection$1 Million for Intellectual Property Protection– $2 Million for US Sales and Marketing$2 Million for US Sales and Marketing– $1 Million for International Distribution$1 Million for International Distribution– $1 Million for Inventory$1 Million for Inventory

• Anticipated IPO or Acquisition in 4 yearsAnticipated IPO or Acquisition in 4 years

Target $100+ Million or 20X Return Target $100+ Million or 20X Return